GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Additional Paid-In Capital

Level Bio AB (XSAT:LEVBIO) Additional Paid-In Capital : kr0.00 Mil(As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Additional Paid-In Capital?


Level Bio AB's quarterly additional paid-in capital increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr17.19 Mil) but then stayed the same from Dec. 2023 (kr17.19 Mil) to Mar. 2024 (kr0.00 Mil).

Level Bio AB's annual additional paid-in capital stayed the same from Dec. 2021 (kr17.19 Mil) to Dec. 2022 (kr17.19 Mil) and stayed the same from Dec. 2022 (kr17.19 Mil) to Dec. 2023 (kr17.19 Mil).


Level Bio AB Additional Paid-In Capital Historical Data

The historical data trend for Level Bio AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Additional Paid-In Capital Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.70 2.70 17.19 17.19 17.19

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 17.19 -

Level Bio AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Level Bio AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB (XSAT:LEVBIO) Business Description

Traded in Other Exchanges
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines